Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Non-Current Debt (2016 - 2019)

Forte Biosciences (FBRX) has disclosed Non-Current Debt for 4 consecutive years, with $22.1 million as the latest value for Q2 2019.

  • Quarterly Non-Current Debt fell 14.8% to $22.1 million in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $22.1 million through Jun 2019, down 14.8% year-over-year, with the annual reading at $26.2 million for FY2018, 622.79% up from the prior year.
  • Non-Current Debt for Q2 2019 was $22.1 million at Forte Biosciences, down from $24.1 million in the prior quarter.
  • The five-year high for Non-Current Debt was $26.2 million in Q4 2018, with the low at $2.0 million in Q1 2018.
  • Average Non-Current Debt over 4 years is $14.6 million, with a median of $10.2 million recorded in 2016.
  • The sharpest move saw Non-Current Debt crashed 77.02% in 2018, then soared 1124.09% in 2019.
  • Over 4 years, Non-Current Debt stood at $10.2 million in 2016, then plummeted by 64.6% to $3.6 million in 2017, then surged by 622.79% to $26.2 million in 2018, then dropped by 15.73% to $22.1 million in 2019.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $22.1 million, $24.1 million, and $26.2 million for Q2 2019, Q1 2019, and Q4 2018 respectively.